世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

組織質量分析イメージング・システムの世界市場成長 2023-2029


Global Tissue Mass Spectrometry Imaging System Market Growth 2023-2029

弊社(LP Info Research)の最新調査によると、世界の組織質量分析イメージングシステム市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション
2023年8月2日 US$3,660
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
99 英語

日本語のページは自動翻訳を利用し作成しています。


 

サマリー

弊社(LP Info Research)の最新調査によると、世界の組織質量分析イメージングシステム市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、組織質量分析イメージングシステムはレビュー期間中のCAGR %で2029年までに100万米ドルの再調整規模になると予測されています。
この調査レポートは、世界の組織質量分析イメージングシステム市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復に伴い、組織質量分析イメージングシステムは今後の市場でも安定した成長が期待される。しかし、Tissue Mass Spectrometry Imaging Systemの普及には、製品の差別化、コストの削減、サプライチェーンの最適化が引き続き重要である。市場関係者は、Tissue Mass Spectrometry Imaging System市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要がある。
質量分析イメージングとは、質量分析技術に基づくイメージング手法である。この方法は、質量分析を通してイメージングするために生物学的サンプルを直接スキャンし、同じ組織スライスまたは組織チップ上の数百の分子の空間分布特性を同時に分析することができる。簡単に言えば、質量分析イメージング技術とは、質量電荷比を決定することで生体分子の標準分子量を分析する質量分析計を用い、専用の質量分析イメージングソフトウェアの制御と相まって、質量分析の助けを借りてイメージングを行う方法である。組織質量分析イメージングシステムは、高パラメータの単一細胞懸濁液検出機能と組織イメージング機能の両方を備えています。組織イメージング研究において、質量分析フローサイトメトリー(CyTOF)超多数の検出チャンネルの利点を最大限に生かし、その性能は従来の免疫組織化学や免疫蛍光技術をはるかに凌ぐ。
主な特徴
Tissue Mass Spectrometry Imaging System市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長:この調査レポートは、組織質量分析イメージングシステム市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分(例:検出チャンネルが100未満、検出チャンネルが100以上)、地域別内訳などが含まれます。
市場促進要因と課題:レポートでは、政府規制、環境問題、技術進歩、消費者の嗜好の変化など、組織質量分析イメージングシステム市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、測定範囲への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。
競合情勢:この調査レポートは、組織質量分析イメージングシステム市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興企業や市場に影響を与える可能性のある企業にもスポットを当てています。
技術開発:この調査レポートは、組織質量分析イメージングシステム産業における最新の技術開発を掘り下げることができます。これには、Tissue Mass Spectrometry Imaging System技術の進歩、Tissue Mass Spectrometry Imaging Systemの新規参入企業、Tissue Mass Spectrometry Imaging Systemの新規投資、Tissue Mass Spectrometry Imaging Systemの将来を形作るその他の技術革新などが含まれます。
川下の事業者の好みこの調査レポートは、組織質量分析イメージングシステム市場における顧客の購買行動と採用動向を明らかにします。顧客の購買決定、組織質量分析イメージングシステム製品の嗜好に影響を与える要因も含まれています。
政府の政策とインセンティブこの調査レポートは、政府の政策とインセンティブが組織質量分析イメージングシステム市場に与える影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、組織マススペクトロメトリーイメージングシステム市場の促進を目的としたその他の施策の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。
環境への影響と持続可能性この調査レポートは、組織質量分析イメージングシステム市場の環境への影響と持続可能性の側面を評価しています。
市場予測と将来展望:調査レポートは、実施した分析に基づいて、組織質量分析イメージングシステム産業の市場予測と展望を提供します。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートでは最後に、業界関係者、政策立案者、投資家への提言を行っています。市場関係者が新たなトレンドを活用し、課題を克服し、組織質量分析イメージングシステム市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
組織マススペクトロメトリーイメージングシステム市場は、タイプ別と用途別に分割される。2018~2029年の期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
検出チャネルが100未満
検出チャネルが100以上
用途別セグメント
神経科学
病理学
栄養学
その他
本レポートはまた、市場を地域別に分けています:
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
スタンダード・バイオツールズ
ウォーターズコーポレーション
イオンパス
日本電子
島津製作所
トランスミット社
サーモフィッシャーサイエンティフィック
インパクト科学機器
mProbe
本レポートで扱う主な質問
世界の組織質量分析イメージングシステム市場の10年展望は?
組織質量分析イメージングシステムの世界市場および地域別市場成長を促進する要因は何か?
市場別、地域別に最も急成長する技術は何か?
組織マススペクトロメトリーイメージングシステムの市場機会は最終市場規模によってどのように異なるのか?
Tissue Mass Spectrometry Imaging Systemのタイプ別、用途別の内訳は?
COVID-19とロシア・ウクライナ戦争の影響は?


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Country/Region, 2018, 2022 & 2029
2.2 Tissue Mass Spectrometry Imaging System Segment by Type
2.2.1 Detection Channel Is Less Than 100
2.2.2 Detection Channel Is Greater Than 100
2.3 Tissue Mass Spectrometry Imaging System Sales by Type
2.3.1 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Type (2018-2023)
2.3.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Type (2018-2023)
2.4 Tissue Mass Spectrometry Imaging System Segment by Application
2.4.1 Neuroscience
2.4.2 Pathology
2.4.3 Nutrition
2.4.4 Others
2.5 Tissue Mass Spectrometry Imaging System Sales by Application
2.5.1 Global Tissue Mass Spectrometry Imaging System Sale Market Share by Application (2018-2023)
2.5.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Application (2018-2023)
3 Global Tissue Mass Spectrometry Imaging System by Company
3.1 Global Tissue Mass Spectrometry Imaging System Breakdown Data by Company
3.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Company (2018-2023)
3.1.2 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Company (2018-2023)
3.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Company (2018-2023)
3.2.1 Global Tissue Mass Spectrometry Imaging System Revenue by Company (2018-2023)
3.2.2 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Company (2018-2023)
3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Company
3.4 Key Manufacturers Tissue Mass Spectrometry Imaging System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tissue Mass Spectrometry Imaging System Product Location Distribution
3.4.2 Players Tissue Mass Spectrometry Imaging System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tissue Mass Spectrometry Imaging System by Geographic Region
4.1 World Historic Tissue Mass Spectrometry Imaging System Market Size by Geographic Region (2018-2023)
4.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tissue Mass Spectrometry Imaging System Market Size by Country/Region (2018-2023)
4.2.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tissue Mass Spectrometry Imaging System Sales Growth
4.4 APAC Tissue Mass Spectrometry Imaging System Sales Growth
4.5 Europe Tissue Mass Spectrometry Imaging System Sales Growth
4.6 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Growth
5 Americas
5.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country
5.1.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023)
5.1.2 Americas Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023)
5.2 Americas Tissue Mass Spectrometry Imaging System Sales by Type
5.3 Americas Tissue Mass Spectrometry Imaging System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region
6.1.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region (2018-2023)
6.1.2 APAC Tissue Mass Spectrometry Imaging System Revenue by Region (2018-2023)
6.2 APAC Tissue Mass Spectrometry Imaging System Sales by Type
6.3 APAC Tissue Mass Spectrometry Imaging System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tissue Mass Spectrometry Imaging System by Country
7.1.1 Europe Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023)
7.1.2 Europe Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023)
7.2 Europe Tissue Mass Spectrometry Imaging System Sales by Type
7.3 Europe Tissue Mass Spectrometry Imaging System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tissue Mass Spectrometry Imaging System by Country
8.1.1 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023)
8.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Type
8.3 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tissue Mass Spectrometry Imaging System
10.3 Manufacturing Process Analysis of Tissue Mass Spectrometry Imaging System
10.4 Industry Chain Structure of Tissue Mass Spectrometry Imaging System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tissue Mass Spectrometry Imaging System Distributors
11.3 Tissue Mass Spectrometry Imaging System Customer
12 World Forecast Review for Tissue Mass Spectrometry Imaging System by Geographic Region
12.1 Global Tissue Mass Spectrometry Imaging System Market Size Forecast by Region
12.1.1 Global Tissue Mass Spectrometry Imaging System Forecast by Region (2024-2029)
12.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tissue Mass Spectrometry Imaging System Forecast by Type
12.7 Global Tissue Mass Spectrometry Imaging System Forecast by Application
13 Key Players Analysis
13.1 Standard BioTools
13.1.1 Standard BioTools Company Information
13.1.2 Standard BioTools Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Standard BioTools Main Business Overview
13.1.5 Standard BioTools Latest Developments
13.2 Waters Corporation
13.2.1 Waters Corporation Company Information
13.2.2 Waters Corporation Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Waters Corporation Main Business Overview
13.2.5 Waters Corporation Latest Developments
13.3 Ionpath
13.3.1 Ionpath Company Information
13.3.2 Ionpath Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.3.3 Ionpath Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ionpath Main Business Overview
13.3.5 Ionpath Latest Developments
13.4 JEOL
13.4.1 JEOL Company Information
13.4.2 JEOL Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.4.3 JEOL Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 JEOL Main Business Overview
13.4.5 JEOL Latest Developments
13.5 SHIMADZU
13.5.1 SHIMADZU Company Information
13.5.2 SHIMADZU Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 SHIMADZU Main Business Overview
13.5.5 SHIMADZU Latest Developments
13.6 TransMIT GmbH
13.6.1 TransMIT GmbH Company Information
13.6.2 TransMIT GmbH Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 TransMIT GmbH Main Business Overview
13.6.5 TransMIT GmbH Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 Impact Scientific Instrument
13.8.1 Impact Scientific Instrument Company Information
13.8.2 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Impact Scientific Instrument Main Business Overview
13.8.5 Impact Scientific Instrument Latest Developments
13.9 mProbe
13.9.1 mProbe Company Information
13.9.2 mProbe Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.9.3 mProbe Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 mProbe Main Business Overview
13.9.5 mProbe Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る


 

Summary

According to our (LP Info Research) latest study, the global Tissue Mass Spectrometry Imaging System market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Tissue Mass Spectrometry Imaging System is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period.
The research report highlights the growth potential of the global Tissue Mass Spectrometry Imaging System market. With recovery from influence of COVID-19 and the Russia-Ukraine War, Tissue Mass Spectrometry Imaging System are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Tissue Mass Spectrometry Imaging System. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Tissue Mass Spectrometry Imaging System market.
Mass spectrometry imaging is an imaging method based on mass spectrometry technology. This method directly scans biological samples for imaging through mass spectrometry, and can simultaneously analyze the spatial distribution characteristics of hundreds of molecules on the same tissue slice or tissue chip. In simple terms, mass spectrometry imaging technology is a method of imaging with the help of mass spectrometry, coupled with the control of specialized mass spectrometry imaging software, using a mass spectrometer that analyzes the standard molecular weight of biomolecules by determining the mass-to-charge ratio. The tissue mass spectrometry imaging system has both high-parameter single-cell suspension detection functions and tissue imaging functions. Maximize the advantages of mass spectrometry flow cytometry (CyTOF) ultra-high number of detection channels in tissue imaging research, and its performance far exceeds traditional immunohistochemistry or immunofluorescence techniques.
Key Features:
The report on Tissue Mass Spectrometry Imaging System market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Tissue Mass Spectrometry Imaging System market. It may include historical data, market segmentation by Type (e.g., Detection Channel Is Less Than 100, Detection Channel Is Greater Than 100), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Tissue Mass Spectrometry Imaging System market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Tissue Mass Spectrometry Imaging System market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Tissue Mass Spectrometry Imaging System industry. This include advancements in Tissue Mass Spectrometry Imaging System technology, Tissue Mass Spectrometry Imaging System new entrants, Tissue Mass Spectrometry Imaging System new investment, and other innovations that are shaping the future of Tissue Mass Spectrometry Imaging System.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Tissue Mass Spectrometry Imaging System market. It includes factors influencing customer ' purchasing decisions, preferences for Tissue Mass Spectrometry Imaging System product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Tissue Mass Spectrometry Imaging System market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Tissue Mass Spectrometry Imaging System market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Tissue Mass Spectrometry Imaging System market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Tissue Mass Spectrometry Imaging System industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Tissue Mass Spectrometry Imaging System market.
Market Segmentation:
Tissue Mass Spectrometry Imaging System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Detection Channel Is Less Than 100
Detection Channel Is Greater Than 100
Segmentation by application
Neuroscience
Pathology
Nutrition
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Standard BioTools
Waters Corporation
Ionpath
JEOL
SHIMADZU
TransMIT GmbH
Thermo Fisher Scientific
Impact Scientific Instrument
mProbe
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tissue Mass Spectrometry Imaging System market?
What factors are driving Tissue Mass Spectrometry Imaging System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tissue Mass Spectrometry Imaging System market opportunities vary by end market size?
How does Tissue Mass Spectrometry Imaging System break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tissue Mass Spectrometry Imaging System by Country/Region, 2018, 2022 & 2029
2.2 Tissue Mass Spectrometry Imaging System Segment by Type
2.2.1 Detection Channel Is Less Than 100
2.2.2 Detection Channel Is Greater Than 100
2.3 Tissue Mass Spectrometry Imaging System Sales by Type
2.3.1 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Type (2018-2023)
2.3.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Type (2018-2023)
2.4 Tissue Mass Spectrometry Imaging System Segment by Application
2.4.1 Neuroscience
2.4.2 Pathology
2.4.3 Nutrition
2.4.4 Others
2.5 Tissue Mass Spectrometry Imaging System Sales by Application
2.5.1 Global Tissue Mass Spectrometry Imaging System Sale Market Share by Application (2018-2023)
2.5.2 Global Tissue Mass Spectrometry Imaging System Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Application (2018-2023)
3 Global Tissue Mass Spectrometry Imaging System by Company
3.1 Global Tissue Mass Spectrometry Imaging System Breakdown Data by Company
3.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Company (2018-2023)
3.1.2 Global Tissue Mass Spectrometry Imaging System Sales Market Share by Company (2018-2023)
3.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Company (2018-2023)
3.2.1 Global Tissue Mass Spectrometry Imaging System Revenue by Company (2018-2023)
3.2.2 Global Tissue Mass Spectrometry Imaging System Revenue Market Share by Company (2018-2023)
3.3 Global Tissue Mass Spectrometry Imaging System Sale Price by Company
3.4 Key Manufacturers Tissue Mass Spectrometry Imaging System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tissue Mass Spectrometry Imaging System Product Location Distribution
3.4.2 Players Tissue Mass Spectrometry Imaging System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tissue Mass Spectrometry Imaging System by Geographic Region
4.1 World Historic Tissue Mass Spectrometry Imaging System Market Size by Geographic Region (2018-2023)
4.1.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tissue Mass Spectrometry Imaging System Market Size by Country/Region (2018-2023)
4.2.1 Global Tissue Mass Spectrometry Imaging System Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tissue Mass Spectrometry Imaging System Sales Growth
4.4 APAC Tissue Mass Spectrometry Imaging System Sales Growth
4.5 Europe Tissue Mass Spectrometry Imaging System Sales Growth
4.6 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales Growth
5 Americas
5.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country
5.1.1 Americas Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023)
5.1.2 Americas Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023)
5.2 Americas Tissue Mass Spectrometry Imaging System Sales by Type
5.3 Americas Tissue Mass Spectrometry Imaging System Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region
6.1.1 APAC Tissue Mass Spectrometry Imaging System Sales by Region (2018-2023)
6.1.2 APAC Tissue Mass Spectrometry Imaging System Revenue by Region (2018-2023)
6.2 APAC Tissue Mass Spectrometry Imaging System Sales by Type
6.3 APAC Tissue Mass Spectrometry Imaging System Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tissue Mass Spectrometry Imaging System by Country
7.1.1 Europe Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023)
7.1.2 Europe Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023)
7.2 Europe Tissue Mass Spectrometry Imaging System Sales by Type
7.3 Europe Tissue Mass Spectrometry Imaging System Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tissue Mass Spectrometry Imaging System by Country
8.1.1 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Revenue by Country (2018-2023)
8.2 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Type
8.3 Middle East & Africa Tissue Mass Spectrometry Imaging System Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tissue Mass Spectrometry Imaging System
10.3 Manufacturing Process Analysis of Tissue Mass Spectrometry Imaging System
10.4 Industry Chain Structure of Tissue Mass Spectrometry Imaging System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tissue Mass Spectrometry Imaging System Distributors
11.3 Tissue Mass Spectrometry Imaging System Customer
12 World Forecast Review for Tissue Mass Spectrometry Imaging System by Geographic Region
12.1 Global Tissue Mass Spectrometry Imaging System Market Size Forecast by Region
12.1.1 Global Tissue Mass Spectrometry Imaging System Forecast by Region (2024-2029)
12.1.2 Global Tissue Mass Spectrometry Imaging System Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tissue Mass Spectrometry Imaging System Forecast by Type
12.7 Global Tissue Mass Spectrometry Imaging System Forecast by Application
13 Key Players Analysis
13.1 Standard BioTools
13.1.1 Standard BioTools Company Information
13.1.2 Standard BioTools Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.1.3 Standard BioTools Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Standard BioTools Main Business Overview
13.1.5 Standard BioTools Latest Developments
13.2 Waters Corporation
13.2.1 Waters Corporation Company Information
13.2.2 Waters Corporation Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.2.3 Waters Corporation Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Waters Corporation Main Business Overview
13.2.5 Waters Corporation Latest Developments
13.3 Ionpath
13.3.1 Ionpath Company Information
13.3.2 Ionpath Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.3.3 Ionpath Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Ionpath Main Business Overview
13.3.5 Ionpath Latest Developments
13.4 JEOL
13.4.1 JEOL Company Information
13.4.2 JEOL Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.4.3 JEOL Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 JEOL Main Business Overview
13.4.5 JEOL Latest Developments
13.5 SHIMADZU
13.5.1 SHIMADZU Company Information
13.5.2 SHIMADZU Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.5.3 SHIMADZU Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 SHIMADZU Main Business Overview
13.5.5 SHIMADZU Latest Developments
13.6 TransMIT GmbH
13.6.1 TransMIT GmbH Company Information
13.6.2 TransMIT GmbH Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.6.3 TransMIT GmbH Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 TransMIT GmbH Main Business Overview
13.6.5 TransMIT GmbH Latest Developments
13.7 Thermo Fisher Scientific
13.7.1 Thermo Fisher Scientific Company Information
13.7.2 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.7.3 Thermo Fisher Scientific Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Thermo Fisher Scientific Main Business Overview
13.7.5 Thermo Fisher Scientific Latest Developments
13.8 Impact Scientific Instrument
13.8.1 Impact Scientific Instrument Company Information
13.8.2 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.8.3 Impact Scientific Instrument Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Impact Scientific Instrument Main Business Overview
13.8.5 Impact Scientific Instrument Latest Developments
13.9 mProbe
13.9.1 mProbe Company Information
13.9.2 mProbe Tissue Mass Spectrometry Imaging System Product Portfolios and Specifications
13.9.3 mProbe Tissue Mass Spectrometry Imaging System Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 mProbe Main Business Overview
13.9.5 mProbe Latest Developments
14 Research Findings and Conclusion

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療)の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る